# ZEVRA THERAPEUTICS INC (ZVRA)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/ZVRA/

- Reporting holders: 4
- Reported value: $10.1K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $4.9K | 445 | 0.0% | 7 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $4.0K | 362 | 0.0% | 9 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $856 | 78 | 0.0% | 4 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $395 | 36 | 0.0% | 3 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 4 | $10.1K |
| Q2 2026 | 162 | $761.1M |
| Q1 2026 | 150 | $419.7M |
| Q4 2025 | 162 | $381.8M |
| Q3 2025 | 167 | $425.7M |
| Q2 2025 | 125 | $330.7M |
| Q1 2025 | 115 | $279.5M |
| Q4 2024 | 113 | $287.4M |
| Q3 2024 | 107 | $210.2M |
| Q2 2024 | 92 | $91.8M |
| Q1 2024 | 88 | $83.0M |
| Q4 2023 | 84 | $103.1M |